|
From the Chinese Academy of Sciences, Shanghai drug study invention of" a class of pancreatic high blood sugar -like peptide -- 1 receptor agonist and the preparation method and use "a few days ago the National Invention Patent. The results obtained at the same time, Russia, Australia, the two patents. involved in the outcome of a class of glucagon-like peptide -1 receptor (GLP-1R) agonist refers to a class can be used as non-peptide GLP-1R agonists to replace the five yuan heterocyclic derivatives small molecule organic compounds, such compounds with GLP-1R have a good combination of capability, can promote the synthesis of cAMP, can be used as a treatment of type โ
|
